As previously described, m6A modifications participate in the regulation of cancer progression [13,14], and we evidenced that the m6A-associated regulators, including METTL3 (Figure S2A), METTL14 (Figure S2B), and FTO (Figure S2C), were all aberrantly upregulated in the PC cell lines compared to the normal HPDE cells. The gene discussed is METTL14; the disease is cancer.